Abstract
Objectives: Gynecologic Oncology Group (GOG) 99 identified a group of high-intermediate risk (HIR) endometrial cancer patients that may benefit from adjuvant treatment; the ideal type of treatment is unknown. Our objective was to compare survival of HIR patients who had various treatments, including chemotherapy (CT), whole pelvic radiation therapy (WPRT) with or without brachytherapy (BT) and observation (OBS).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
